.

About the Study

Thank you for your interest in the CEASAR Study.  CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation) is a multi-site research program that has enrolled more than 3,600 men with a diagnosis of localized prostate cancer.  The study began in 2010, and includes participants enrolled from the following six sites:

  • CaPSURE - University of California-San Francisco Cancer of the Prostate Strategic Urologic Research Endeavor (San Francisco)
  • Emory University (Atlanta, Georgia)
  • Lousiana State University Health Sciences Center (New Orleans, Louisiana)
  • State of New Jersey Department of Health (Trenton, New Jersey)
  • University of Southern California (Los Angeles, California)
  • University of Utah (Salt Lake City, Utah)

Three rounds of surveys have so far been completed: baseline survey at time of diagnosis; 6-month follow-up; and 12-month follow-up.  The three-year follow-up survey will be conducted beginning in March 2014.

Our ongoing goal for CEASAR is to help learn more about what treatment works best, for which patients, in whose hands.  To learn more about the current status of the CEASAR Study, please click here to view our March 2014 CEASAR Newsletter.

This page was last updated March 13, 2014 and is maintained by